Serum creatinine phosphokinase activity in psychiatric patients receiving electroconvulsive therapy
Taylor, P.J.; Von Witt, R.J.; Fry, A.H.
Journal of Clinical Psychiatry 42(3): 103-105
1981
ISSN/ISBN: 0160-6689 PMID: 7204348 Document Number: 171191
Elevation of serum creatine phosphokinase (CPK) has been demonstrated in patients with organic brain pathology. It has been alleged that electroconvulsive therapy (ECT) produces significant brain damage. In a group of patients receiving ECT, the levels remained within normal limits although a small rise in skeletal muscle type CPK was demonstrated following treatment. In no case was any brain type CPK isolated.